Liraglutide for Breastfeeding: Evidence, Eligibility

The Liraglutide label on breastfeeding: It is not known whether it passes into human breast milk.

A quick look at Saxenda

How long it remains in the body

The half-life is about 13 hours. After 13 h, half is gone, and five half-lives leave about 3% (2.7 d).

Main trial weight loss results

In the SCALE Obesity and Prediabetes, 56-week study, body weight fell by 7.4%, against 3% on placebo.

Liraglutide label: breastfeeding
Medicine	What the label says
Victoza	It is not known whether it passes into human breast milk.
Saxenda	It is not known whether it passes into human breast milk.

These details appear in the FDA labels: DailyMed label 1 2.

These warnings appear in the label: FDA label on DailyMed.

GLP-1 medicines and breastfeeding
Medicine	What the label says	How it is taken
Saxenda	It is not known whether it passes into human breast milk.	daily injection
Victoza	It is not known whether it passes into human breast milk.	daily injection
Ozempic	It is not known whether it passes into human breast milk.	weekly injection
Wegovy	SNAC is in the tablets, and breast milk also contains it; for the injection, passage into breast milk is not known.	weekly injection or daily tablet
Rybelsus	SNAC is in the tablets, and breast milk also contains it.	daily tablet
Mounjaro	In a small study, levels in breast milk were undetectable or low.	weekly injection
Zepbound	In a small study, levels in breast milk were undetectable or low.	weekly injection
Foundayo	It is not known whether it passes into human breast milk.	daily tablet
Trulicity	It is not known whether it passes into human breast milk.	weekly injection
Byetta	It is not known whether it passes into human breast milk.	twice-daily injection